Search results
Feb 3, 2021 · The Moderna COVID-19 vaccine has been authorised for use in Singapore in individuals aged 18 years and above. The first shipment arrived in Singapore on 17 February 2021. Details of the Moderna COVID-19 vaccine. For individuals aged 18 years and above; Two doses required, administered 28 days apart; High vaccine efficacy of 94%
Feb 3, 2021 · The Health Sciences Authority (HSA) granted an interim authorisation today under the Pandemic Special Access Route (PSAR) for the Moderna COVID-19 vaccine to be used in Singapore for the prevention of Coronavirus Disease 2019 (COVID-19) in individuals aged 18 years and above.
Ongoing clinical trials globally. Meet Moderna. Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. Learn more about us. Join us and change the world of medicine. Life at Moderna. So, what is mRNA? Messenger RNA (mRNA) already exists in your body.
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering. Report Adverse Events You can report any adverse events to Moderna via the Adverse Event Intake Portal or by calling 1-800-622-4937.
The Moderna/Spikevax vaccines have been authorised by the Health Sciences Authority (HSA) for use in Singapore. The vaccines are available for persons aged 6 months and above.
Pfizer-BioNTech, Moderna and Novavax have successfully obtained full registration for their vaccines. Sinovac-CoronaVac vaccine continues to be included under the National Vaccination Programme (NVP)* until 30 September 2024.
Oct 14, 2022 · The Ministry of Health (MOH) will be bringing forward the administration of the bivalent Moderna/Spikevax vaccine from 17 October 2022, which was previously announced, to 14 October 2022.
Sep 19, 2022 · SINGAPORE - The Health Sciences Authority (HSA) on Wednesday granted interim authorisation for the use of Moderna's Spikevax bivalent Covid-19 vaccine, which targets both the original...
The Moderna COVID-19 vaccine protects against COVID-19. The vaccine contains messenger RNA (mRNA) which helps your immune system to produce protection. The vaccine reduces the risks of infection and severe disease from COVID-19, and has good protection against the current virus variants.
Aug 24, 2022 · The Health Sciences Authority (HSA) has extended the authorisation of Moderna’s Spikevax COVID-19 vaccine via the Pandemic Special Access Route (PSAR) on 24 August 2022, for the prevention of Coronavirus Disease 2019 (COVID-19) in individuals of the following age groups:
